Positive Clinical Readouts Validate Potential of Proprietary Delivery Platforms and Cement Global Leadership in RNAi Therapeutics Business Highlights Promising progress in clinical development After an End of Phase-II meeting and with guidance from the U.S. FDA, the Group is advancing the…